Epocrates and Covisint Help Physicians Secure PQRI Incentives

SAN MATEO, Calif.--(BUSINESS WIRE)--Epocrates, Inc., the leading provider of point-of-care reference solutions, today announced it is working with Covisint, a Compuware (NASDAQ: CPWR) Company, to help medical professionals successfully receive reimbursements from the Center for Medicare & Medicaid Services (CMS) Physician Quality Reporting Initiative (PQRI) program. The collaboration will help the nearly 300,000 U.S. physicians in the Epocrates network benefit from the 2010 pay-for-reporting program via Covisint's DocSite solution.

"Epocrates has an outstanding reach to hundreds of thousands of physicians," said John Haughton, M.D., chief medical information officer for Covisint, a Compuware Company. "Now, with Covisint, physicians in Epocrates' network will easily achieve PQRI status - a low-risk first step in the clinical payment process that enables physicians to deliver better healthcare and get paid more efficiently."

Epocrates products and services are designed to support physicians' delivery of high-quality patient care. With the complementary goal of improving care and cutting costs, CMS has focused this year's PQRI program on a number of chronic conditions, including kidney disease, back pain and diabetes mellitus. Through Covisint's streamlined, CMS-certified DocSite PQRI registry, eligible professionals can efficiently report on quality measures for those and other conditions. Epocrates is raising awareness of Covisint's convenient DocSite system that also facilitates qualifying physicians' receipt of the available financial incentive.

"Epocrates' focus has always been on helping physicians in their daily workflow and increasing the efficiency of their practice," said Sean Handel, vice president for Epocrates' subscriber business. "Covisint and its DocSite solution significantly reduce the time and labor involved with the PQRI program, freeing up physicians' time to do what matters most - provide quality care for their patients."

Covisint DocSite has assisted healthcare professionals submit PQRI data since 2007 and assisted more than 4,500 providers with submitting data to CMS for the 2009 PQRI reporting year. With more than 45 percent of U.S. physicians using its products and services, Epocrates is in a position to help more physicians learn about the Covisint DocSite registry and complete the documentation process with ease.

ABOUT COVISINT, a Compuware Company

Covisint, a Compuware company, enables information ecosystems that quickly revolutionize organizations by providing secure communication and collaboration between people and systems in remarkably simple ways. Covisint is a recognized cloud computing pioneer driving the on-demand revolution that helps organizations connect, communicate and collaborate with their partners--enabling anywhere, anytime information. The Covisint ExchangeLinkTM platform provides industry-specific services for identity management, collaborative portals and data exchange, as well as a third-party application marketplace. Learn more at www.covisint.com.

ABOUT EPOCRATES, INC.

Epocrates is a leading provider of mobile drug reference tools and interactive services to healthcare professionals and the healthcare industry. Epocrates' active user network currently has more than one million healthcare professionals, including more than 45 percent of U.S. physicians. Most commonly used on mobile devices at the point of care, the company's clinical products and services help healthcare professionals make more informed prescribing decisions, enhance patient safety and improve practice productivity. For more information about Epocrates, please visit www.epocrates.com/company.

All trademarks are properties of their respective owners.

Contacts

Epocrates, Inc.
Erica Sniad Morgenstern, 650-227-6907
[email protected]

Suggested Articles

The profit margins and management of Community Health Group raise questions about oversight of managed care insurers.

Financial experts are warning practices about the pitfalls of promoting medical credit cards to their patients.

A proposed rule issued by HHS on Tuesday would expand short-term coverage, a move Seema Verma said will have "virtually no impact" on ACA premiums.